Briviact

FDA approves generic Tamiflu, plus 2 other new drugs
FDA approves generic Tamiflu, plus 2 other new drugsFDA approved the first generic version of oseltamivir phosphate (Tamiflu, Roche) for oral suspension to treat influenza A and B, plus 2 other noteworthy therapies.
FDA approves brivaracetam for use in partial onset seizure treatmentBrivaracetam provides another adjunctive treatment option for partial onset seizures in patients with uncontrolled epilepsy.
FDA clears new treatment for epileptic seizuresFDA has approved brivaracetam (Briviact, UCB, Inc.) as an add-on therapy for the treatment of partial onset-seizures in patients with epilepsy.